Information Library
Case Studies - Get to market faster
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions. -
Takeda Hits the Ground Running in New European Territory, with Help from Innovex
September 25, 2009
Our customer was faced with the challenge to launch a countrywide sales team in Spain within 12 weeks. -
Oncology Product Launch – Nurse Educators Surpass Demanding Fast-Track Goals
August 27, 2009
Learn how Innovex worked with a large pharma company to recruit, train and deploy a team of highly qualified Oncology Nurse Educators in just five weeks – to underpin a very demanding launch. -
Blockbuster reaches 7 new markets in record time
August 13, 2009
This study looks at a fully paid up member of ‘Big Pharma’ and its preparation for the international launch of one of its blockbuster drugs. It examines how outsourcing enabled them to get to market in time and then quickly out-perform the competition. -
Outsourcing for Pan-European launch success
August 13, 2009
This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible. -
Syndicated Community Nurse Program Boosts Territory Coverage and Sales
June 29, 2009
Innovex was able to boost performance for a woundcare customer by 8,000 contacts in just eight months. -
Grabbing a Leadership Position
March 26, 2009
Astellas-NovaQuest Alliance Establishes Market Leadership Platform for Vesicare -
Driving Near Term Sales & Savings
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, funded a dedicated sales force of 150 experienced Innovex cardiovascular representatives for two years, in return for a five-year royalty on the net sales of Advicor and its predecessor product, Niaspan®. PharmaBio also received warrants to purchase shares of Kos Pharmaceuticals stock. -
Harnessing a Speciality Salesforce
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, committed more than $400 million in milestone payments and sales force services to fund the launch of Cymbalta and support commercialization efforts for five years. A dedicated service company created by PharmaBio Development is providing more than 500 Innovex sales representatives to supplement the extensive Lilly primary care and specialty sales forces. -
How to Keep All Your Licenses in Compliance
March 25, 2009
Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses.